Digestive Disease Week

Early ERCP reduces LOS, costs of acute pancreatitis without cholangitis

Posted on: 13/06/2015 - 16:57

Washington – When it’s given early in the course of treatment for patients who have acute pancreatitis and biliary obstruction without cholangitis, endoscopic retrograde cholangiopancreatography...

Field of Interest: Gastroentero...

Type: News Item

DDW: Top-down Crohn’s treatment holds up with longer scrutiny

Posted on: 07/06/2015 - 21:56

WASHINGTON – More intensive treatment with early combined immunosuppression was associated with a longer time to first flare and fewer flares than conventional management during long-term follow-up...

Field of Interest: Gastroentero...

Type: News Item

DDW: Uveitis significantly more common in black patients with IBD

Posted on: 04/06/2015 - 20:00

WASHINGTON – Black patients with inflammatory bowel disease were significantly more likely to have at least one extraintestinal manifestation of the disease than were white patients, particularly...

Field of Interest: Gastroentero...

Type: News Item

DDW: Anti-MAdCAM antibody hits endpoints in treatment-refractory UC

Posted on: 29/05/2015 - 18:43

WASHINGTON – The anti-MAdCAM candidate, PF-00547659, induced responses in up to 54% of patients with moderately to severely active ulcerative colitis failing at least one prior therapy. At the...

Field of Interest: Gastroentero...

Type: News Item

DDW: Antibiotic rifaximin eases functional dyspepsia symptoms

Posted on: 22/05/2015 - 19:36

WASHINGTON – Two weeks of antibiotic therapy with rifaximin provided relief from functional dyspepsia symptoms in a phase III...

Field of Interest: Gastroentero...

Type: News Item

DDW: Ozanimod active in moderate-severe UC, without cardiac signal in TOUCHSTONE trial

Posted on: 20/05/2015 - 16:36

WASHINGTON– The oral S1P receptor modulator ozanimod is clinically active and well tolerated in patients with moderate to severe ulcerative colitis (UC), phase II study results show. Importantly, no...

Field of Interest: Gastroentero...

Type: News Item

DDW: Statin use associated with significantly lower risk of new-onset IBD

Posted on: 16/05/2015 - 21:33

WASHINGTON – A prescription for a statin was associated with about a 40% lower risk of new-onset inflammatory bowel disease in a study that evaluate... More »

Field of Interest: Gastroentero...

Type: News Item

Increased intestinal permeability is central to alcoholic hepatitis

Posted on: 16/06/2014 - 20:30

CHICAGO – Why is it that only about 20% of individuals who consume 10 or more alcoholic drinks daily for years on end will develop alcoholic hepatitis? New insight into the mechanism of this...

Field of Interest: Gastroentero...

Type: News Item

Mesalazine didn’t help diarrhea-predominant IBS

Posted on: 10/06/2014 - 19:40

CHICAGO – Treating diarrhea-predominant irritable bowel syndrome with mesalazine for 12 weeks failed to improve stool frequency or other symptoms, compared with placebo, in a multicenter, randomized...

Field of Interest: Gastroentero...

Type: News Item

Novel noninvasive therapy for extraesophageal reflux

Posted on: 10/06/2014 - 14:15

CHICAGO – A novel, externally worn device for the treatment of extraesophageal reflux proved effective, safe, and well tolerated in a multicenter clinical trial. "Given the poor response to...

Field of Interest: Gastroentero...

Type: News Item

Early ERCP reduces LOS, costs of acute pancreatitis without cholangitis

DDW: Top-down Crohn’s treatment holds up with longer scrutiny

DDW: Uveitis significantly more common in black patients with IBD

DDW: Anti-MAdCAM antibody hits endpoints in treatment-refractory UC

DDW: Antibiotic rifaximin eases functional dyspepsia symptoms

DDW: Ozanimod active in moderate-severe UC, without cardiac signal in TOUCHSTONE trial

DDW: Statin use associated with significantly lower risk of new-onset IBD

Increased intestinal permeability is central to alcoholic hepatitis

Mesalazine didn’t help diarrhea-predominant IBS

Novel noninvasive therapy for extraesophageal reflux

Newsletters

Latest Newsletters

You are here

Digestive Disease Week

Newsletters

Latest Newsletters